Due to the observed anti-cancer effectiveness of mTOR inhibitors in preclinical studies, either as standalone treatments or in combination with chemotherapy, radiotherapy, and targeted therapy, numerous clinical trials have been completed or are currently underway to assess the efficacy of mTOR inhibitors in the treatment of various types of human cancers. This evidence concerns the gene MTOR and cancer.